InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,834.18
(
1.55%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

glass_half_full

Send PM Follow Ignore
Followers 6
Posts 1203
Boards Moderated 0
Alias Born 12/09/2006

glass_half_full

Re: cushsix post# 9394

Thursday, 06/16/2011 8:12:05 AM

Thursday, June 16, 2011 8:12:05 AM

Post# of 80490
True, Q3 starts July 1, but my working assumption is that when they say Q3, we won't see anything until September.

Since their original time frame for '113 to enter the clinic was "summer" (which, true, also includes much of September) I take this as pushing the timeline back a bit. I guess, since Autumn starts on 9/23, it's only the potential for a 1-week delay.

What interests me is that they are officially disclosing this as a "Phase 1/2 trial" -- is this something new from the FDA?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up